Persistence with topical glaucoma therapy in Japan from the perspective of product, formulation, and patient characteristics: analysis of medical insurance claim data

This study provides the first comprehensive analysis of product-specific persistence rates for topical glaucoma therapies in Japan. Product choice was shown to significantly influence persistence, alongside known factors such as patient sex, age, drug class, and dose/day. These findings have implications for drug development, product selection, and patient counseling aimed at improving the effectiveness and efficiency of long-term glaucoma management.